Coherus BioSciences, Inc. - 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Coherus BioSciences, Inc. (CHRS) on December 4, 2024, reporting an event that occurred on November 27, 2024. The filing pertains to corporate governance changes rather than financial performance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to the announcement of a director's departure and contains no financial data.
Material Changes
The material change reported is the resignation of Kimberly J. Tzoumakas from the Board of Directors, effective December 31, 2024. The Company stated that the resignation was not the result of any disagreement with the Company regarding its operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies. The only commentary provided is a statement of gratitude for Ms. Tzoumakas's service and contributions during her tenure.
Key Facts for Investors to Verify
- Kimberly J. Tzoumakas resigned from the Board of Directors effective December 31, 2024.
- The resignation was voluntary and not due to any disagreement with the Company.
- The Company has not announced a replacement director in this filing.
- No financial results or operational updates were included in this specific report.